Financing ·
Intelligent Bio Solutions Inc. closed a private placement on September 2, 2026, issuing 2,036,659 shares and…
INBSIntelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc. closed a private placement on September 2, 2026, issuing 2,036,659 shares and associated warrants to a single institutional investor for approximately $5.0 million in gross proceeds. The transaction includes Series N-1 and Series N-2 warrants exercisable at $2.33 per share, with the N-1 warrants callable upon FDA 510(k) clearance of its drug screening system. Proceeds are designated for working capital and general corporate purposes. Intelligent Bio Solutions Inc. operates in the medical technology industry, developing non-invasive testing solutions such as fingerprint-based drug screening systems.